• 学术搜索
  • 科研智能体
    • Research Labs
    • AI 阅读
    • AI 文库
    • 深度研究
    • 学者亮点
  • 学术资源
    • AI2000
    • 期刊/会议
    • 学者库
    • 学术API
      MCP&Skill
    • 溯源树
    • 数据集
  • 知识沉淀
    • 学术空间
订阅小程序
旧版功能
aminer vip
开通会员低至0.73元/天
一次搞定AI科研
立即登录
  • English
  • 联系方式
    Expert review of molecular diagnostics

    Expert review of molecular diagnostics

    JournalISSN 1473-7159eISSN 1744-8352中科院 医学 3区

    年发文量

    研究主题

    论文(2672)

    排序
    1NewBiomarker-led Advances in Renal Cell Carcinoma Diagnosis, Progression Monitoring and Therapeutic Decision-Making
    Francesco M. Lasorsa,Savio Domenico Pandolfo,Francesco Claps,Luca Lambertini,Martina Milella,Monica Rutigliano,Matteo Ferro,Pasquale Ditonno, Giuseppe Tiziano Lucarelli

    Renal cell carcinoma (RCC) diagnosis and management remain challenging due to asymptomatic presentation and limitations in accurately characterizing small renal masses. Noninvasive liquid biopsy biomarkers, including circulating proteins, metabolites, cell-free DNA, microRNAs, and inflammatory markers, have emerged as promising tools for RCC detection, prognostic stratification, and treatment monitoring. Here we review recent advances in blood- and urine-based biomarkers, highlighting key findings such as the diagnostic accuracy of kidney injury molecule-1 (KIM-1), CA15-3, metabolomic signatures, and urinary protein panels, alongside the prognostic relevance of circulating tumor DNA and systemic inflammatory indices. Despite encouraging analytical and clinical validity, no biomarker has yet demonstrated clinical utility due to biological, methodological, and regulatory challenges. Continued efforts focusing on standardized protocols, prospective validation, and integration with imaging and clinical data are essential to translate these biomarkers into personalized RCC management strategies.

    2026
    引用
    AI阅读
    加入学术空间
    2NewMicroRNA-based Point-of-care Diagnostics for Emerging and Re-Emerging Infectious Diseases: from Biomarker Discovery to Clinical Implementation
    Victoria Cappleman,Himanshu Gupta
    2026
    引用
    AI阅读
    加入学术空间
    3NewDecoding Prognosis: Multigene Expression Assays in Breast Cancer
    Charanjit Kaur, Drishti Agarwal

    INTRODUCTION Breast cancer remains a leading cause of cancer-related death in women worldwide. In early-stage, hormone receptor-positive/-negative disease, tissue-based multigene expression assays refine prognosis and guide systemic therapy. Axillary nodal status is still determined by clinical examination, imaging and sentinel lymph node biopsy (SLNB). AREAS COVERED This narrative review separates prognostic, predictive and nodal-staging information. For MammaPrint, Oncotype DX, PAM50/Prosigna, EndoPredict and Breast Cancer Index, it summarizes the platform, validated population, level of evidence and guideline status. These assays estimate distant-recurrence risk and/or benefit from chemotherapy or extended endocrine therapy; none was developed or validated to predict nodal involvement. The dedicated gene-expression panels for nodal metastasis derive from retrospective or single-cohort studies, lack prospective validation and are not recommended for axillary staging. Liquid biopsy (ctDNA), multi-omics approaches, and cost, access and standardization are also reviewed. EXPERT OPINION The established assays answer narrow, population-specific answers on recurrence and systemic-treatment benefit, not axillary staging; omission of SLNB currently rests on clinical and radiological criteria (SOUND, INSEMA). Nodal signatures remain investigational, and ctDNA and multi-omics approaches are promising but not yet practice-changing, requiring prospective trials showing improved outcomes. Age- and menopausal-status-related chemotherapy effects derive largely from exploratory or subgroup analyses and are hypothesis-generating.

    2026
    引用
    AI阅读
    加入学术空间
    4NewDecoding Ewing Sarcoma: from EWSR1::FLI1 Translocation to Advanced Diagnostic Approaches
    Anjali Maurya, Savy Panamkuttiyiel Minal,Sunil Kumar, Neha Ramani,Subhash Chandra Yadav
    2026
    引用
    AI阅读
    加入学术空间
    5NewSalivary Exosomes: Emerging Diagnostic Modalities for Cancer, Brain and Immunological Disorders.
    Nidhi Verma,Madaswamy S. Muthu
    2026
    引用
    AI阅读
    加入学术空间
    立即登录,查看全部 2672 篇论文

    高被引作者

    作者引用发文
    Alireza Tahamtan15963
    Ardebili Abdollah15861
    Madhukar Pai122010
    Keertan Dheda10793
    Shriprakash Kalantri10662
    Sze-Chuen Cesar Wong103418
    Hin Fung Tsang101417
    Peter Lin10103
    Chen Changyi10103
    Qizhi Cathy Yao9652

    高产作者

    作者引用发文
    William C. S. Cho46122
    Claire Raison920
    Dimitrios Roukos72219
    Sze-Chuen Cesar Wong103418
    Hin Fung Tsang101417
    Liang Cheng28917
    Rodolfo Montironi29316
    Jenaid Rees014
    Francesco Massari25214
    Antonio Lopez-Beltran20014

    相关期刊

    American journal of clinical pathology
    Critical reviews in clinical laboratory sciences
    Journal of clinical pathology
    Journal of clinical laboratory analysis
    Clinical laboratory
    Clinical and Experimental Medicine
    Biomedical journal
    Clinical Chemistry
    APMIS
    Cell Reports Medicine